These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 21436070)

  • 41. Elevated Expression of miR-19b Enhances CD8
    Yin LB; Song CB; Zheng JF; Fu YJ; Qian S; Jiang YJ; Xu JJ; Ding HB; Shang H; Zhang ZN
    Front Immunol; 2018; 9():3140. PubMed ID: 30687333
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Limited immune restoration after 3 years' suppression of HIV-1 replication in patients with moderately advanced disease.
    Valdez H; Connick E; Smith KY; Lederman MM; Bosch RJ; Kim RS; St Clair M; Kuritzkes DR; Kessler H; Fox L; Blanchard-Vargas M; Landay A;
    AIDS; 2002 Sep; 16(14):1859-66. PubMed ID: 12351945
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prolonged Antiretroviral Therapy in Adolescents With Vertical HIV Infection Leads to Different Cytokine Profiles Depending on Viremia Persistence.
    Munhoz LGC; Garcia Spina F; Machado DM; Gouvea A; Succi RCM; Diaz RS; De Moraes-Pinto MI
    Pediatr Infect Dis J; 2019 Nov; 38(11):1115-1120. PubMed ID: 31626046
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunologic failure despite suppressive antiretroviral therapy is related to activation and turnover of memory CD4 cells.
    Lederman MM; Calabrese L; Funderburg NT; Clagett B; Medvik K; Bonilla H; Gripshover B; Salata RA; Taege A; Lisgaris M; McComsey GA; Kirchner E; Baum J; Shive C; Asaad R; Kalayjian RC; Sieg SF; Rodriguez B
    J Infect Dis; 2011 Oct; 204(8):1217-26. PubMed ID: 21917895
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Factors Associated With the Control of Viral Replication and Virologic Breakthrough in a Recently Infected HIV-1 Controller.
    Walker-Sperling VE; Pohlmeyer CW; Veenhuis RT; May M; Luna KA; Kirkpatrick AR; Laeyendecker O; Cox AL; Carrington M; Bailey JR; Arduino RC; Blankson JN
    EBioMedicine; 2017 Feb; 16():141-149. PubMed ID: 28159573
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HIV Latency Is Established Directly and Early in Both Resting and Activated Primary CD4 T Cells.
    Chavez L; Calvanese V; Verdin E
    PLoS Pathog; 2015 Jun; 11(6):e1004955. PubMed ID: 26067822
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CD4+ T cell receptor repertoire perturbations in HIV-1 infection: association with plasma viremia and disease progression.
    Malhotra U; Huntsberry C; Holte S; Lee J; Corey L; McElrath MJ
    Clin Immunol; 2006 Apr; 119(1):95-102. PubMed ID: 16403675
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impaired in-vitro growth of megakaryocytic colonies derived from CD34 cells of HIV-1-infected patients with active viral replication.
    Costantini A; Giuliodoro S; Mancini S; Butini L; Regnery CM; Silvestri G; Greco F; Leoni P; Montroni M
    AIDS; 2006 Aug; 20(13):1713-20. PubMed ID: 16931935
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Duration and predictors of CD4 T-cell gains in patients who continue combination therapy despite detectable plasma viremia.
    Deeks SG; Barbour JD; Grant RM; Martin JN
    AIDS; 2002 Jan; 16(2):201-7. PubMed ID: 11807304
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quantitative and qualitative assessment of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ T cell immunity to gag in HIV-1-infected individuals with differential disease progression: reciprocal interferon-gamma and interleukin-10 responses.
    Ostrowski MA; Gu JX; Kovacs C; Freedman J; Luscher MA; MacDonald KS
    J Infect Dis; 2001 Nov; 184(10):1268-78. PubMed ID: 11679915
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of secondary lymphatic tissue in immune deficiency of HIV infection.
    Schacker T
    AIDS; 2008 Sep; 22 Suppl 3():S13-8. PubMed ID: 18845917
    [TBL] [Abstract][Full Text] [Related]  

  • 52. "Discordant" increases in CD4 cell count relative to plasma viral load in a closely followed cohort of patients initiating antiretroviral therapy.
    Wood E; Hogg RS; Yip B; Tyndall MW; Sherlock CH; Harrigan RP; O'Shaughnessy MV; Montaner JS
    J Acquir Immune Defic Syndr; 2002 Jun; 30(2):159-66. PubMed ID: 12045678
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increased soluble Fas in HIV-infected hemophilia patients with CD4+ and CD8+ cell count increases and viral load and immune complex decreases.
    Daniel V; Süsal C; Weimer R; Zimmermann R; Huth-Kühne A; Opelz G
    AIDS Res Hum Retroviruses; 2001 Mar; 17(4):329-35. PubMed ID: 11242519
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Monocyte Based Correlates of Immune Activation and Viremia in HIV-Infected Long-Term Non-Progressors.
    Prabhu VM; Singh AK; Padwal V; Nagar V; Patil P; Patel V
    Front Immunol; 2019; 10():2849. PubMed ID: 31867010
    [No Abstract]   [Full Text] [Related]  

  • 55. Elevated Level of CD4
    Xia H; Jiang W; Zhang X; Qin L; Su B; Li Z; Sun J; Zhang Y; Zhang T; Lu X; Wu H
    Front Immunol; 2018; 9():616. PubMed ID: 29636753
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pneumocystis jiroveci pneumonia prophylaxis is not required with a CD4+ T-cell count < 200 cells/microl when viral replication is suppressed.
    D'Egidio GE; Kravcik S; Cooper CL; Cameron DW; Fergusson DA; Angel JB
    AIDS; 2007 Aug; 21(13):1711-5. PubMed ID: 17690568
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evidence of immune reconstitution in antiretroviral drug-experienced patients with advanced HIV disease.
    Landay AL; Bettendorf D; Chan E; Spritzler J; Schmitz JL; Bucy RP; Gonzalez CJ; Schnizlein-Bick CT; Evans T; Squires KE; Phair JP
    AIDS Res Hum Retroviruses; 2002 Jan; 18(2):95-102. PubMed ID: 11839142
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Low blood CD8+ T-lymphocytes and high circulating monocytes are predictors of HIV-1-associated progressive encephalopathy in children.
    Sánchez-Ramón S; Bellón JM; Resino S; Cantó-Nogués C; Gurbindo D; Ramos JT; Muñoz-Fernández MA
    Pediatrics; 2003 Feb; 111(2):E168-75. PubMed ID: 12563091
    [TBL] [Abstract][Full Text] [Related]  

  • 59. HIV-1 dynamics after transient antiretroviral therapy: implications for pathogenesis and clinical management.
    Phillips AN; McLean A; Johnson MA; Tyrer M; Emery V; Griffiths P; Bofill M; Janossy G; Loveday C
    J Med Virol; 1997 Nov; 53(3):261-5. PubMed ID: 9365893
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 'Modeling' relationships among HIV-1 replication, immune activation and CD4+ T-cell losses using adjusted correlative analyses.
    Lederman MM; Kalish LA; Asmuth D; Fiebig E; Mileno M; Busch MP
    AIDS; 2000 May; 14(8):951-8. PubMed ID: 10853976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.